Journal article
OptimAAPP, a smartphone insulin dose calculator for carbohydrate, fat, and protein: A cross-over, randomised controlled trial in adolescents and adults with type 1 diabetes using multiple daily injection therapy
TA Smith, N Venkatesh, K Roem, JC Lu, E Netzer, A Medioli, S Szwec, DN O'Neal, BR King, CE Smart
Diabetic Medicine | WILEY | Published : 2025
DOI: 10.1111/dme.15487
Abstract
Aims: To (1) evaluate the efficacy of OptimAAPP, a smartphone insulin dose calculator for carbohydrate, fat, and protein in managing glycaemia compared with carbohydrate counting in adolescents and adults with type 1 diabetes using flexible multiple daily injection therapy (MDI, ≥4 injections/day) and (2) assess user acceptability of OptimAAPP. Methods: In this free-living trial, participants aged 12–50 years were randomised to use carbohydrate counting or OptimAAPP for meal insulin dose calculation for 3 months, then use the alternate method for 3 months. The primary outcome, time-in-range (3.9–10.0 mmol/L) was measured in weeks 3–4 of each arm using continuous glucose monitoring. The accep..
View full abstractGrants
Funding Acknowledgements
The authors would like to acknowledge the research support provided by the Mothers and Babies Research Centre, Hunter Medical Research Institute, New Lambton Heights and Catriona Sims of the University of Melbourne, Parkville and funding agencies the Australian Diabetes Educators Research Foundation and John Hunter Hospital Charitable Trust. The authors would especially like to thank the participants and their families that took part in this study.